| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Psychosomatic Medicine, Vol 60, Issue 6 752-758, Copyright © 1998 by American Psychosomatic Society
ORIGINAL ARTICLES |
MS Kopp, PR Falger, A Appels and S Szedmak
Institute of Behavioural Sciences, Semmelweis University of Medicine, Budapest, Hungary. kopmar@net.sote.hu
OBJECTIVE: This study proposes to assess the differences of two psychosocial risk indicators for coronary artery disease (CAD), ie, depressive symptoms and vital exhaustion. METHOD: In a representative, stratified, nation-wide sample of the population of Hungary over the age of 16 years (N = 12,640), analyses were made of whether those risk indicators were differentially related to several illness behaviors (including history of cardiovascular treatment and cardiovascular sick days), cognitions, mood states, and socioeconomic characteristics that may generally be associated with increased CAD risk. The sample was stratified by age, sex, and composition of the population of all counties in Hungary. RESULTS: Although depressive symptoms and vital exhaustion correlated strongly, there were clear and significant differences in strength of association between depressive symptoms, vital exhaustion and several variables under study. Dysfunctional cognitions, hostility, lack of purpose in life, low perceived self-efficacy, illegal drug use, alcohol and drug abuse, several forms of subjective disability complaints and history of treatment because of congenital disorders, and chronic skin and hematological disorders were more often associated with depressive symptoms, whereas loss of energy, use of stimulants, chest-pain-related disabilities, history of treatment because of cardiovascular disorders, and self-reported cardiovascular sick days were significantly more often associated with vital exhaustion. CONCLUSIONS: Vital exhaustion and depressive symptomatology are differentially associated with relevant external criteria. Vital exhaustion is associated with perceived cardiovascular complaints and history of cardiovascular treatment, whereas depressive symptomatology seems to be more closely connected to disabilities and complaints related to alcohol, drug, and congenital-disorder, and to dysfunctional cognitions and hostility.
This article has been cited by other articles:
![]() |
M. S Kopp, A. Stauder, G. Purebl, I. Janszky, and A. Skrabski Work stress and mental health in a changing society Eur J Public Health, June 1, 2008; 18(3): 238 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Arnold Understanding Fatigue in Major Depressive Disorder and Other Medical Disorders Psychosomatics, May 1, 2008; 49(3): 185 - 190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. KOPP, A. SKRABSKI, A. SZEKELY, A. STAUDER, and R. WILLIAMS Chronic Stress and Social Changes: Socioeconomic Determination of Chronic Stress Ann. N.Y. Acad. Sci., October 1, 2007; 1113(1): 325 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Szekely, P. Balog, E. Benko, T. Breuer, J. Szekely, M. D. Kertai, F. Horkay, M. S. Kopp, and J. F. Thayer Anxiety Predicts Mortality and Morbidity After Coronary Artery and Valve Surgery A 4-Year Follow-Up Study Psychosom Med, September 1, 2007; 69(7): 625 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wattanakit, J. E Williams, P. J Schreiner, A. T Hirsch, and A. R Folsom Association of anger proneness, depression and low social support with peripheral arterial disease: the Atherosclerosis Risk in Communities Study Vascular Medicine, August 1, 2005; 10(3): 199 - 206. [Abstract] [PDF] |
||||
![]() |
W. Lim, S. Hong, R. Nelesen, and J. E. Dimsdale The Association of Obesity, Cytokine Levels, and Depressive Symptoms With Diverse Measures of Fatigue in Healthy Subjects Arch Intern Med, April 25, 2005; 165(8): 910 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Appels, F. Bar, G. van der Pol, R. Erdman, M. Assman, W. Trijsburg, R. van Diest, J. van Dixhoorn, and C. M. de Leon Effects of Treating Exhaustion in Angioplasty Patients on New Coronary Events: Results of the Randomized Exhaustion Intervention Trial (EXIT) Psychosom Med, March 1, 2005; 67(2): 217 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Jeanmonod, R. von Kanel, F. E. Maly, and J. E. Fischer Elevated Plasma C-Reactive Protein in Chronically Distressed Subjects Who Carry the A Allele of the TNF-{alpha} -308 G/A Polymorphism Psychosom Med, July 1, 2004; 66(4): 501 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Golden, J. E. Williams, D. E. Ford, H.-C. Yeh, C. Paton Sanford, F. J. Nieto, and F. L. Brancati Depressive Symptoms and the Risk of Type 2 Diabetes: The Atherosclerosis Risk in Communities study Diabetes Care, February 1, 2004; 27(2): 429 - 435. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Kopp, C. T. Csoboth, and J. Rethelyi Psychosocial Determinants of Premature Health Deterioration in a Changing Society: The Case of Hungary J Health Psychol, January 1, 2004; 9(1): 99 - 109. [Abstract] [PDF] |
||||
![]() |
E. Prescott, C. Holst, M. Gronbaek, P. Schnohr, G. Jensen, and J. Barefoot Vital exhaustion as a risk factor for ischaemic heart disease and all-cause mortality in a community sample. A prospective study of 4084 men and 5479 women in the Copenhagen City Heart Study Int. J. Epidemiol., December 1, 2003; 32(6): 990 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Wirtz, R. von Kanel, P. Schnorpfeil, U. Ehlert, K. Frey, and J. E. Fischer Reduced Glucocorticoid Sensitivity of Monocyte Interleukin-6 Production in Male Industrial Employees who are Vitally Exhausted Psychosom Med, July 1, 2003; 65(4): 672 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Bardwell, P. Moore, S. Ancoli-Israel, and J. E. Dimsdale Fatigue in Obstructive Sleep Apnea: Driven by Depressive Symptoms Instead of Apnea Severity? Am J Psychiatry, February 1, 2003; 160(2): 350 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Skrabski, M Kopp, and I Kawachi Social capital in a changing society: cross sectional associations with middle aged female and male mortality rates J. Epidemiol. Community Health, February 1, 2003; 57(2): 114 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rutledge, W. Linden, and R. F. Davies Psychological Risk Factors May Moderate Pharmacological Treatment Effects Among Ischemic Heart Disease Patients Psychosom Med, November 1, 1999; 61(6): 834 - 841. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |